The FDAs Center for Drug Evaluation
and Research (CDER), Office of Regulatory Affairs (Central Region and Philadelphia
District) are sponsoring a Town Meeting specifically targeted to help small drug companies
understand regulatory requirements for approval and marketing. This provides an
opportunity to dialogue with subject matter experts from CDER and the Field on a variety
of topics of interest to the small business community. There is no charge for attendance,
but seating will be limited, so please mark your calendars and plan to register early. Date
and Location:
Wednesday, March 5, 2003
12:00-4:00 PM
William J. Green Federal Building, 6th and Arch Street
Conference Rooms A & B, 2nd Floor
Philadelphia, PA 19106
Presentations to include:
- OTC Monographs and Labeling - David Hilfiker, Supervisory Project Manager, Division of
OTC Drug Products, CDER
- Pre-IND Meetings and the FDA Meetings Process - Judit Milstein, Regulatory Project
Manager, Division of Anti-Infective Drug Products; Office of Drug Evaluation, CDER
- Communicating with the FDA - Navigating the FDA Website - Marie Falcone, Small Business
Representative, ORA Central Region
- Requirements for Importation and Exportation of Drug Products - Ada Irizarry, Senior
Compliance Officer, Office of Compliance/CDER
- The Drug Registration and Listing System - Kathy Y. Smith, Project Officer (Sr.
Management Analyst) Drug Registration and Listing System (DRLS), Division of Data
Management and Services (DDMS)/Office of Information Technology and David Mazyck, DRLS
Manager, DDMS
- Financial Incentives - Ronald Wilson, Director, Small Business Assistance, CDER
For further information please contact:
Ms. Marie Falcone, Small Business Representative
Central Region, FDA
Mfalcone@ora.fda.gov
Mr. Ron Wilson
Director, Small Business Assistance
CDER, FDA
Wilsonr@cder.fda.gov |